Cisplatin/gefitinib/pemetrexed: Lack of efficacy in metastatic lung cancer: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1365, 2011-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conjugated estrogens/gefitinib interaction: First report of an interaction, leading to loss of efficacy of gefitinib in lung cancer: case report

By  

Reactions Weekly, Vol. 1, Iss. 1289, 2010-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Gefitinib: Lung injury: case report

By  

Reactions Weekly, Vol. 1, Iss. 1096, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Gefitinib: Lung disorders: case report

By  

Reactions Weekly, Vol. 1, Iss. 1095, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Cisplatin/pemetrexed: Toxic epidermal necrolysis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1387, 2012-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Gefitinib: Interstitial lung disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1180, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite